Mostrando 7 resultados de: 7
Filtros aplicados
Publisher
American Journal of Therapeutics(2)
Revista Latinoamericana de Hipertension(2)
Anales del Sistema Sanitario de Navarra(1)
Current Nutrition and Food Science(1)
European Endocrinology(1)
Área temáticas
Bioquímica(1)
Farmacología y terapéutica(1)
Fisiología humana(1)
Mammalia(1)
Medicina forense; incidencia de enfermedades(1)
Área de conocimiento
Enfermedad cardiovascular(3)
Medicina interna(3)
Biología molecular(1)
Bioquímica(1)
Diabetes(1)
Origen
scopus(7)
Clinical and nutritional implications of kidney disease and COVID-19
ReviewAbstract: By the end of 2019 emerged a cluster of pneumonia that was caused by a novel SARS-CoV-2 virus. The dPalabras claves:acute kidney injury, Chronic kidney disease, Clinical nutrition, covid-19, nutritional, SARS-COV-2Autores:Albornoz C., Ariza D., Carrasquero R., D’marco L., Guerra-Torres X.E., Morillo V., Nava M., Valmore Bermúdez, Vasquez H.E.A.Fuentes:scopusDetermination of Non-HDL cholesterol in diabetic and hypertensive patients
ArticleAbstract: Recently, it has been suggested that non-high-density lipoprotein (non-HDL) cholesterol measure is aPalabras claves:atherosclerosis, LDL, Non-HDL cholesterolAutores:Castro J., Contreras F., Dowling V., González M.C., Guerra-Torres X.E., Lares M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusNon-albuminuric Diabetic Kidney Disease Phenotype: Beyond Albuminuria
ReviewAbstract: Diabetic kidney disease (DKD) is the leading cause of chronic and end-stage kidney disease worldwidePalabras claves:Albuminuria, Cardiovascular disease, Chronic kidney disease, DIABÉTESAutores:D’marco L., Guerra-Torres X.E., Lopez-Romero L., Valmore Bermúdez, Viejo I., Yugueros A.Fuentes:scopusPathogenic mechanisms of SARS-CoV-2 infection and kidney disease: a clinical and molecular perspective
ArticleAbstract: The SARS-CoV-2 infection has become as a worldwide public health emergency. It exhibits a variety ofPalabras claves:acute kidney injury, Angiotensin-conver-ting enzyme 2, Chronic kidney disease, covid-19, SARS-COV-2Autores:D’marco L., Guerra-Torres X.E., Lameda V., Manzano A., Medina O., Morillo V., Nava M., Parra H., Puchades M.J., Suarez M.K., Torres W., Valmore BermúdezFuentes:scopusLipoprotein (a): Molecular and Epidemiologic basis about its role in cardiovascular diseases
ReviewAbstract: In 1963, Kare Berg at the University of Oslo discovered Lp(a) as a new human plasmatic antigen set.Palabras claves:Apolipoprotein(a), Atherogenesis, Cardiovascular disease, lipoprotein(a), Lp (a), thrombogenesisAutores:Aparicio D., Arráiz N., Canelón R., Cano-Ponce C., Cizcek A., Faria J., Gotera D., Guerra-Torres X.E., Manuel V., Rojas E.R., Sorell L.T., Valmore BermúdezFuentes:scopusLipoprotein(a): From molecules to therapeutics
ReviewAbstract: Lipoprotein (a) [Lp(a)] was discovered by Kare Berg in 1963 from the study of low-density lipoproteiPalabras claves:Atherogenesis, Cardiovascular disease, Hyperlipoproteinemia(a), lipoprotein(a), therapeuticsAutores:Amell A., Aparicio D., Arráiz N., Cabrera M., Canelón R., Cano R.A., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Mengual-Moreno E., Reyna-Villasmil N., Rojas E.R., Sorell L.T., Valmore Bermúdez, Velasco M.Fuentes:scopusUnusually elevated levels of lipoprotein(a) in Afro-American populations from south of Lake Maracaibo
ArticleAbstract: Objective. Lipoproteína(a), [Lp(a)], is an independent risk factor for coronary artery disease. In VPalabras claves:Apo(a), Cardiovascular disease, Lipoprotein (a), risk factorAutores:Amell A., Aparicio D., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Linares S., Medina M.T., Mengual-Moreno E., Nuñez M., Reyna-Villasmil N., Rojas E.R., Seyfi H.A., Sorell L.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopus